Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-05-01 | Dr. Ruoslahti was appointed to the Board in September 2022, and prior to that he served as a member of the Cend Therapeutics, Inc. board of directors since 2015. |
Data sourced from SEC filings. Last updated: 2025-07-01